OptimizeRx
(NASDAQ) OPRX
OptimizeRx Financials at a Glance
Market Cap
$120.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$107.35M
Net Income (TTM)
$6.84M
EPS (TTM)
$0.35
P/E Ratio
18.15
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Price
$6.40
Volume
166,535.483
Open
$6.32
Price
$6.40
Volume
166,535.483
Open
$6.32
Previous Close
$6.41
Daily Range
$6.24 - $6.45
52-Week Range
$4.54 - $22.25
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Price
$6.40
Volume
166,535.483
Open
$6.32
Previous Close
$6.41
Daily Range
$6.24 - $6.45
52-Week Range
$4.54 - $22.25
Estimated Earnings Date
Aug 6, 2026
OPRX News
OPRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout OptimizeRx
Industry
Health Care Technology
Sector
Health CareEmployees
133
CEO
Stephen L. Silvestro
Website
www.optimizerx.comHeadquarters
Waltham, MA 02453, US
OPRX Financials
Key Financial Metrics (TTM)
Gross Margin
69.05%
Operating Margin
13.57%
Net Income Margin
6.37%
Return on Equity
5.47%
Return on Capital
7.81%
Return on Assets
4.09%
Earnings Yield
5.51%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$120.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
18.77M
Volume
166.54K
Avg. Volume
474.49K
Financials (TTM)
Gross Profit
$74.12M
Operating Income
$14.57M
EBITDA
$18.90M
Operating Cash Flow
$14.38M
Capital Expenditure
-$52.00K
Free Cash Flow
$14.33M
Cash & ST Invst.
$20.17M
Total Debt
$23.72M
OptimizeRx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$19.84M
-9.5%
Gross Profit
$13.87M
+3.9%
Gross Margin
69.89%
N/A
Market Cap
$120.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$884.44K
N/A
Employees
136
N/A
Net Income
-$495.00K
+77.5%
EBITDA
$1.58M
+276.4%
Quarterly Fundamentals
Total Cash
$20.17M
+21.7%
Total Debt
$23.72M
-27.7%
Accounts Receivable
$32.86M
+0.1%
Inventory
$0.00
N/A
Long Term Debt
$21.54M
-26.6%
Short Term Debt
$2.18M
-36.7%
Return on Assets
4.09%
N/A
Return on Invested Capital
9.29%
N/A
Free Cash Flow
-$488.00K
-112.7%
Operating Cash Flow
-$467.00K
-112.1%